A 4-Part Phase 1 Study to Evaluate the Effect of GDC-0853 on the Pharmacokinetics of Midazolam, Rosuvastatin, and Simvastatin and the Effect of Itraconazole on the Pharmacokinetics of GDC-0853
Latest Information Update: 26 Sep 2019
At a glance
- Drugs Fenebrutinib (Primary) ; Itraconazole; Midazolam; Rosuvastatin; Simvastatin
- Indications Autoimmune disorders; Rheumatoid arthritis; Systemic lupus erythematosus; Urticaria
- Focus Pharmacokinetics
- Sponsors Genentech
- 25 Sep 2017 Status changed from active, no longer recruiting to completed.
- 06 Jun 2017 New trial record